A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.

TL;DR: In this article, the authors assess the survival rates of patients with prostate cancer in the Samara Region over the period 2010-2014 taking into consideration their age and the given treatment.

TL;DR: The purpose of the statement is to reorient patients away from any perception that prostate cancer is generally fatal, and it would be perfectly reasonable to adapt the schema to local circumstances or for individual clinicians to choose words based on what they believe best reflects the research evidence.

TL;DR: A large Swedish population-based study has shown that 15-year prostate-cancer-related mortality rates are negligible for men with low-risk cancers treated noncuratively, but significant for those with intermediate-risk and high-risk tumours.

TL;DR: This article proposes methods for combining estimates of the cause-specific hazard functions under the proportional hazards formulation, but these methods do not allow the analyst to directly assess the effect of a covariate on the marginal probability function.

TL;DR: The most recent data on cancer incidence, mortality, and survival from the American Cancer Society (ACS) is presented in this paper, where the authors compare the three major cancer sites in men (lung, prostate, and colon and rectum [colorectum]) and in two major cancers sites in women (breast and colorectal) over a 15-year period.

TL;DR: In this paper, a class of tests developed for comparing the cumulative incidence of a particular type of failure among different groups is presented. The tests are based on comparing weighted averages of the hazards of the subdistribution for the failure type of interest.